(Reuters) - The Canadian health sciences company said it earned $736
million, or $5.35 a share, for the second quarter, up from $14
million, or 10 cents a share, for the same period last year.
On an adjusted basis, earnings per share were 11 cents for
the quarter, up from 8 cents a share for the same quarter last
year.
Read more at Reuters.com Market News
million, or $5.35 a share, for the second quarter, up from $14
million, or 10 cents a share, for the same period last year.
On an adjusted basis, earnings per share were 11 cents for
the quarter, up from 8 cents a share for the same quarter last
year.
Read more at Reuters.com Market News
No comments:
Post a Comment